๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of SB-247083, a potent and selective endothelinA receptor antagonist, in the rat, dog, and monkey

โœ Scribed by Keith W. Ward; Leonard M. Azzarano; Jayme A. Morgan; Michael J. Gould; Cherng-Yih Perng; Pamela R. Souder; David Lundberg; Brian R. Smith

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
119 KB
Volume
23
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The pharmacokinetics and metabolism of D
The pharmacokinetics and metabolism of DuP 532, a non-peptide angiotensin II receptor antagonist, in rats and dogs
โœ Y. N. Wong; K. A. Holm; D. L. Burcham; S.-M. Huang; C. Y. Quon ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 481 KB ๐Ÿ‘ 1 views

DuP 532, 2-propy1-4-pentafluoroethyl-l-[ [2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylJ imidazole-5-carboxylic acid, is an orally active, non-peptide angiotensin I1 (AII) receptor antagonist. DuP 532 is more potent and longer acting than losartan, another A11 receptor antagonist currently undergoing ph

Effect of H2-receptor antagonists on the
Effect of H2-receptor antagonists on the pharmacokinetics of 5-fluorouracil in the rat and monkey
โœ Mark R. Dilloway; F. Lant ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 530 KB

The effect of short term (7 days) and long term (28 days) pretreatment with the imidazole H,-receptor antagonist, cimetidine (CMT), on the pharmacokinetics of 5-fluorouracil (5-FUra) has been studied in the rat and cynomolgus monkey. Short-term pretreatment of rats with CMT significantly increased b

The pharmacokinetics and metabolism of C
The pharmacokinetics and metabolism of CP-191,166, an angiotensin II receptor antagonist, in rats and dogs
โœ Mary C. Allen; Mark R. Nocerini; Wesley W. Day ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 177 KB ๐Ÿ‘ 1 views

166 is an orally active, non-peptide angiotensin II (AII) receptor antagonist developed for the treatment of hypertension and congestive heart failure (CHF). In this study, the intravenous (iv) and oral (po) single dose pharmacokinetics (PK), oral multiple dose PK and P450-mediated metabolism of 16

Effects of pentobarbital on pharmacokine
Effects of pentobarbital on pharmacokinetics and pharmacodynamics of a potent fibrinogen receptor antagonist, L-734 217, in dogs
โœ T. Prueksaritanont; M. T. Stranieri; E. L. Hand; J. D. Ellis; M. A. Holahan; G. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 364 KB ๐Ÿ‘ 2 views

Eects of pentobarbital on pharmacokinetics and pharmacodynamics of L-734 217, a potent ยฎbrinogen receptor antagonist, were studied in male dogs. L-734 217 was given intravenously at 0ยด01 mg kg 71 , in a cross-over fashion, to conscious dogs or to dogs anesthetized with pentobarbital. Plasma concentr